The U.S. Food and Drug Administration (FDA) has added 14 drugs or drug classes to a watch list of drugs flagged for potentially serious adverse events.
According to Medscape, the watch list was created to reflect “potential signals of serious risk or new safety information” gathered from reports made through the FDA Adverse Event Reporting System (FAERS).
Once a drug is placed on the list, the FDA evaluates the drug to determine if there is a causal relationship between the drug and adverse events reported. If a causal link is observed, the FDA can order further regulatory action or remove the product from the market completely.
The latest watch list is based on possible safety issues noted by the FDA during the first three months of 2017 and includes actions taken by the FDA as of June 30, 2017.